Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (3) Blüthgen, Nils (2) Burkert, Christian Martin (1) Conrad, Thomas Dr. (1) Dörr, Jan Rafael (1) Forbes, Martin Dr. (1) Henssen, Anton Prof. Dr. med. (12) Kempa, Stefan Dr. (2) Kirchner, Marieluise Dr. (1) Mastrobuoni, Guido Dr. (2) Mertins, Philipp Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Röefzaad, Claudia (2) Schwarz, Roland Dr. (2) Wolf, Jana Prof. Dr. (1) 2004 (2) 2006 (1) 2008 (6) 2009 (5) 2010 (4) 2011 (3) 2012 (4) 2013 (5) 2014 (1) 2015 (2) 2016 (2) 2017 (6) 2018 (1) 2019 (1) 2020 (10) 2021 (9) 2022 (11) 2023 (5) 2024 (1) Advanced Light Microscopy (43) AG Müller/Dechend (ECRC) (472) AG Schreiber [ECRC] (57) Allosteric Proteomics Lab (18) Anchored Signalling (114) Angiogenesis & Metabolism Laboratory (58) Animal Phenotyping (50) Biobank (423) Bioinformatics and Omics Data Science (90) Bioinformatics of RNA Structure and Transcriptome Regulation (47) Biology of Malignant Lymphomas (97) Biomedical Image Analysis (53) Cancer Genetics and Cellular Stress Responses (96) Cardiac MRI (283) Cardiovascular-Hematopoietic Interaction (16) Cell Biology of Immunity (61) Cellular Neurosciences (456) Chromatin (dys)function in disease (19) Clinical Research Unit (21) Clinic of Psychiatry / Modul Psychiatry of Aging (68) Computational methodologies and omic analytics (13) Computational Regulatory Genomics (168) Cryo-Electron Microscopy (17) Developmental Biology / Signal Transduction (211) Developmental Neurobiology (110) Development and Function of Neural Circuits (34) Electron Microscopy (7) Endocrinology, Diabetes and Nutritional Medicine (36) (-) Epigenetic Modifications in Neuroblastoma (79) Epigenetic Regulation and Chromatin Architecture (128) Experimental Ultrahigh-Field MR (339) Flow Cytometry (8) From Cell States to Function (8) Gastrointestinal Barrier, Regeneration and Carcinogenesis (44) Genetics and Genomics of Cardiovascular Diseases (431) Genetics of Congenital Heart Disease (69) Genetics of Metabolic and Reproductive Disorders (24) Genome Diversification & Integrity (29) Genome Engineering & Disease Models (156) Genome instability and somatic mosaicism (41) Genomics (347) Host-microbiome factors in cardiovascular disease (137) Hypertension-caused End-Organ Damage (472) Hypertension-Mediated End-Organ Damage (472) Image Data Analysis (15) immune Cell Function in Health and Disease (35) Immune Dysregulations in Oncology (69) Immune Mechanisms and Human Antibodies (23) Immune Regulation and Cancer (95) Innate Immunity & Neuroinflammation (67) In Situ Structural Biology (55) Integrative Vascular Biology (162) Interdisciplinary Retina Research (110) Intracellular Proteolysis (138) Kidney Cell Engineering (17) Magnetic Resonance (339) Mathematical Cell Physiology (126) Mathematical Modelling of Cellular Processes (60) Mechanism-based Cancer Therapies (86) Microenvironmental Regulation in Autoimmunity and Cancer (84) Mobile DNA (188) Molecular and cellular basis of behavio (9) Molecular Biology of Peptide Hormones (786) Molecular Cardiovascular Research (205) Molecular Epidemiology (423) Molecular Genetics of Chronic Inflammation and Allergic Disease (89) Molecular Immunology and Gene Therapy (239) Molecular mechanisms of environment sensing (12) Molecular Oncology (27) Molecular Pathways in Cortical Development (30) Molecular Physiology of Somatic Sensation (174) Myology (135) Nephrology and Inflammatory Vascular Diseases (159) Neural Circuits and Behaviour (62) Neuroimmunology Laboratory (51) Neurovascular link in neuroendocrine tumors (8) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (28) Organoids (10) Out-patient Clinic for Neuroimmunology (680) Out-patient Clinic for Pediatric Allergology and Atopic Dermatitis (89) Pancreatic Organoid Research and Disease Modeling (130) Pathogenesis of ANCAinduced Glomerulonephritis (110) Pluripotent Stem Cells (71) Protein Production and Characterization (28) Proteome Dynamics (138) Proteomics (135) Proteomics and Metabolomics (99) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (377) Psychoneuroimmunology (47) Quantitative Developmental Biology (50) Quantitative Stem Cell Biology (28) RNA Biology and Posttranscriptional Regulation (140) Single Molecule Biophysics probing Quantitative Neuroscience (14) Spatial Proteomics (26) Stem Cell Dynamics and Mitochondrial Genomics (43) Stem Cell Modeling of Development and Disease (20) Structural Biology of Membrane-Associated Processes (110) Synaptic Transmission and Plasticity (209) Systems Biology Imaging (35) Systems biology of cardiovascular and neuronal pathologies (11) Systems Biology of Gene Regulatory Elements (190) Systems Hematology, Stem Cells & Precision Medicine (46) Transgenics (156) Translational Approaches in Heart Failure and Cardiometabolic Disease (120) Translational Bioinformatics (104) Translational Cardiology and Functional Genomics (103) Translational Neuroimmunology (56) Translational Oncology of Solid Tumors (917) Translational Organ Models (75) Translational Tumorimmunology (33) Tumor heterogeneity and treatment resistance in pediatric cancer (8) 79 Results: Active Filter: Epigenetic Modifications in Neuroblastoma Sort: Result score Newest to oldest Oldest to newest June 15, 2010 / Clin Cancer Res HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth T. Milde I. Oehme A. Korshunov A. Kopp-Schneider M. Remke P. Northcott H.E. Deubzer M. Lodrini M.D. Taylor A. von Deimling S. Pfister O. Witt January 15, 2010 / Biochem Pharmacol Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines M. Michaelis M.C. Kleinschmidt S. Barth F. Rothweiler J. Geiler R. Breitling B. Mayer H. Deubzer O. Witt J. Kreuter H.W. Doerr J. Cinatl J. Cinatl November 01, 2009 / Expert Opin Investig Drugs Targeting of HDAC8 and investigational inhibitors in neuroblastoma I. Oehme H.E. Deubzer M. Lodrini T. Milde O. Witt May 08, 2009 / Cancer Lett HDAC family: What are the cancer relevant targets? O. Witt H.E. Deubzer T. Milde I. Oehme March 01, 2009 / Genes Chromosomes Cancer Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma T. Milde S. Pfister K. Korshunov H.E. Deubzer I. Oehme A. Ernst A. Starzinski-Powitz A. Seitz P. Lichter A. von Deimling O. Witt January 01, 2009 / Clin Cancer Res Histone deacetylase 8 in neuroblastoma tumorigenesis I. Oehme H.E. Deubzer D. Wegener D. Pickert J.P. Linke B. Hero A. Kopp-Schneider F. Westermann S.M. Ulrich A. von Deimling M. Fischer O. Witt January 01, 2009 / Curr Pharm Des Targeting histone deacetylases in neuroblastoma. O. Witt H.E. Deubzer M. Lodrini T. Milde I. Oehme November 18, 2008 / Cancer Lett Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells J.H. Schulte J. Kirfel S. Lim A. Schramm N. Friedrichs H.E. Deubzer O. Witt A. Eggert R. Buettner October 16, 2008 / Clin Cancer Res Cisplatin-resistant neuroblastoma cells express enhanced levels of epidermal growth factor receptor (EGFR) and are sensitive to treatment with EGFR-specific toxins M. Michaelis J. Bliss S.C. Arnold N. Hinsch F. Rothweiler H.E. Deubzer O. Witt K. Langer H.W. Doerr W.S. Wels J. Cinatl October 01, 2008 / Anticancer Drugs HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells D. Wegener H.E. Deubzer I. Oehme T. Milde C. Hildmann A. Schwienhorst O. Witt Pagination First page « First Previous page ‹ Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next › Last page Last »
June 15, 2010 / Clin Cancer Res HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth T. Milde I. Oehme A. Korshunov A. Kopp-Schneider M. Remke P. Northcott H.E. Deubzer M. Lodrini M.D. Taylor A. von Deimling S. Pfister O. Witt
January 15, 2010 / Biochem Pharmacol Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines M. Michaelis M.C. Kleinschmidt S. Barth F. Rothweiler J. Geiler R. Breitling B. Mayer H. Deubzer O. Witt J. Kreuter H.W. Doerr J. Cinatl J. Cinatl
November 01, 2009 / Expert Opin Investig Drugs Targeting of HDAC8 and investigational inhibitors in neuroblastoma I. Oehme H.E. Deubzer M. Lodrini T. Milde O. Witt
May 08, 2009 / Cancer Lett HDAC family: What are the cancer relevant targets? O. Witt H.E. Deubzer T. Milde I. Oehme
March 01, 2009 / Genes Chromosomes Cancer Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma T. Milde S. Pfister K. Korshunov H.E. Deubzer I. Oehme A. Ernst A. Starzinski-Powitz A. Seitz P. Lichter A. von Deimling O. Witt
January 01, 2009 / Clin Cancer Res Histone deacetylase 8 in neuroblastoma tumorigenesis I. Oehme H.E. Deubzer D. Wegener D. Pickert J.P. Linke B. Hero A. Kopp-Schneider F. Westermann S.M. Ulrich A. von Deimling M. Fischer O. Witt
January 01, 2009 / Curr Pharm Des Targeting histone deacetylases in neuroblastoma. O. Witt H.E. Deubzer M. Lodrini T. Milde I. Oehme
November 18, 2008 / Cancer Lett Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells J.H. Schulte J. Kirfel S. Lim A. Schramm N. Friedrichs H.E. Deubzer O. Witt A. Eggert R. Buettner
October 16, 2008 / Clin Cancer Res Cisplatin-resistant neuroblastoma cells express enhanced levels of epidermal growth factor receptor (EGFR) and are sensitive to treatment with EGFR-specific toxins M. Michaelis J. Bliss S.C. Arnold N. Hinsch F. Rothweiler H.E. Deubzer O. Witt K. Langer H.W. Doerr W.S. Wels J. Cinatl
October 01, 2008 / Anticancer Drugs HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells D. Wegener H.E. Deubzer I. Oehme T. Milde C. Hildmann A. Schwienhorst O. Witt